N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation - Gianquinto, Eleonora; Sodano, Federica; Rolando, Barbara; Kostrzewa, Magdalena; Allarà, Marco; Mahmoud, Ali Mokhtar; Kumar, Poulami; Spyrakis, Francesca; Ligresti, Alessia; Chegaev, Konstantin (Molecules (Basel, Switzerland), 2022)
Keywords: Agonists; Antibiotics; Apoptosis; Cannabinoid Receptor Agonists - chemistry; cannabinoid receptors; Cannabinoids; drug design; hCB2R selective ligands; Humans; in silico simulations; Ligands; Marijuana; mechanism of receptor activation; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Small libraries; Structure-Activity Relationship; Sulfonamides; hCB2R selective ligands; in silico simulations; cannabinoid receptors; drug design; mechanism of receptor activation